The advanced oxidation protein products as potential diagnostic and prognostic factor in diseases of the indicated participation of oxidative stress;Zaawansowane produkty utleniania białek jako potencjalny czynnik diagnostyczny i prognostyczny w chorobach o wskazywanym udziale stresu oksydacyjnego

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 446-458

  Piwowar, Agnieszka ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Advanced oxidation protein products; Autoimmune diseases; Cancers diseases; Genetic diseases; Neurodegenerative diseases; Oxidative stress; Pregnancy

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; FEMALE; HUMAN; INFECTION; METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS;

ADVANCED OXIDATION PROTEIN PRODUCTS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HUMANS; INFECTION; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84912132368     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1101545     Document Type: Review

References (108)

1. Agarwal A., Gupta S., Sharma R.K.: Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol., 2005; 3: 28
2. Agarwal A., Gupta S., Sikka S.: The role of free radicals and antioxidants in reproduction. Curr. Opin. Obstet. Gynecol., 2006; 18: 325-332
3. Aksoy F., Yildirim Y.S., Veyseller B., Demirhan H., Ozturan O.: Serum levels of advanced oxidation protein products in response to allergen exposure in allergic rhinitis. Ear Nose Throat J., 2012; 91: E32-E35
4. Alagozlu H., Gorgul A., Bilgihan A., Tuncer C., Unal S.: Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Clin. Res. Hepatol. Gastroenterol., 2013; 37: 80-85
5. Alderman C.J., Shah S., Foreman J.C., Chain B.M., Katz D.R.: The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic. Biol. Med., 2002; 32: 377-385
6. Avinash S.S., Anitha M., Vinodchandran, Rao G.M., Sudha K., Shetty B.V.: Advanced oxidation protein products and total antioxidant activity in colorectal carcinoma. Indian J. Physiol. Pharmacol., 2009; 53: 370-374
7. Barut O., Vural P., Sirin S., Aydin S., Dizdar Y.: The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma. Acta Odontol. Scand., 2012; 70: 303-308
8. Baskol G., Demir H., Baskol M., Kilic E., Ates F., Karakukcu C., Ustdal M.: Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem. Funct., 2006; 24: 307-311
9. Baskol G., Gumus K., Oner A., Arda H., Karakucuk S.: The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur. J. Ophthalmol., 2008; 18: 792-798
10. Baskol G., Karakucuk S., Öner A., Mirza G.A., Kocer D.: Serum MDA and AOPP levels in age related macular degeneration. Erciyes Tip Dergisi, 2004; 26: 7-11
11. Baskol G., Korkmaz S., Erdem F., Caniklioglu A., Kocyigit M., Aksu M.: Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med., 2012; 13: 414-418
12. Baskol M., Baskol G., Kocer D., Ozbakir O., Yucesoy M.: Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis. J. Clin. Gastroenterol., 2008; 42: 687-691
13. Bellieni C.V., Iantorno L., Perrone S., Rodriguez A., Longini M., Capitani S., Buonocore G.: Even routine painful procedures can be harmful for the newborn. Pain, 2009; 147: 128-131
14. Belo L., Caslake M., Santos-Silva A., Castro E.M., Pereira-Leite L., Quintanilha A., Rebelo I.: LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis, 2004; 177: 391-399
15. Buonocore G., Perrone S., Longini M., Terzuoli L., Bracci R.: Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr. Res., 2000; 47: 221-224
16. Buonocore G., Perrone S., Longini M., Vezzosi P., Marzocchi B., Paffetti P., Bracci R.: Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr. Res., 2002; 52: 46-49
17. Całkosiński I., Dobrzyński M., Całkosińska M., Seweryn E., Bronowicka-Szydełko A., Dzierzba K., Ceremuga I., Gamian A.: Charakterystyka odczynu zapalnego. Postępy Hig. Med. Dos̈w., 2009; 63: 395-408
18. Cardenas-Rodriguez N., Huerta-Gertrudis B., Rivera-Espinosa L., Montesinos-Correa H., Bandala C., Carmona-Aparicio L., Coballase-Urrutia E.: Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models. Int. J. Mol. Sci., 2013; 14: 1455-1476
19. Cervellati C., Cremonini E., Bosi C., Magon S., Zurlo A., Bergamini C.M., Zuliani G.: Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease. Curr. Alzheimer Res., 2013; 10: 365-372
20. Chandramathi S., Suresh K., Anita Z.B., Kuppusamy U.R.: Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J. Cancer Res. Clin. Oncol., 2009; 135: 319-323
21. Chandramathi S., Suresh K.G., Anita Z.B., Kuppusamy U.R.: Attenuation of hydrogen peroxide and ferric reducing/antioxidant power serum levels in colorectal cancer patients with intestinal parasitic infection. Malays. J. Med. Sci., 2009; 16: 15-20
22. Chandramathi S., Suresh K., Anita Z.B., Kuppusamy U.R.: Elevated levels of urinary hydrogen peroxide, advanced oxidative protein product (AOPP) and malondialdehyde in humans infected with intestinal parasites. Parasitology, 2009; 136: 359-363
23. Chang D., Sha Q., Zhang X., Liu P., Rong S., Han T., Liu P., Pan H.: The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma. PLoS One, 2011; 6: e27218
24. Chiu-Braga Y.Y., Hayashi S.Y., Schafranski M., Messias-Reason I.J.: Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int. J. Cardiol., 2006; 109: 275-276
25. Da Silva A.S., Paim F.C., Santos R.C., Sangoi M.B., Moresco R.N., Lopes S.T., Jaques J.A., Baldissarelli J., Morsch V.M., Monteiro S.G.: Nitric oxide level, protein oxidation and antioxidant enzymes in rats infected by Trypanosoma evansi. Exp. Parasitol., 2012; 132: 166-170
26. Demirbilek M.E., Kilic N., Komurcu H.F., Akin K.O.: Advanced oxidation protein products in aged with dementia. Am. J. Immunol., 2007; 3: 52-55
27. Dobryszycka W., Leszek J., Rymaszewska J.: Choroba Alzheimera - patogeneza, diagnostyka, leczenie. Wyd. Continuo, Wrocław 2002, wyd. 1
28. Fialová L., Kalousová M., Soukupová J., Malbohan I., Krofta L., Mikulíková L., Horejsová H., Stipek S., Zima T.: Levels of advanced oxidation protein products (AOPP) in the first trimester of pregnancy. Sb. Lek., 2003; 104: 95-102
29. Fialová L., Malbohan I., Kalousová M., Soukupová J., Krofta L., Stipek S., Zima T.: Oxidative stress and inflammation in pregnancy. Scand. J. Clin. Lab. Invest., 2006; 66: 121-127
30. Fulgenzi A., Wasserman K., Corsi M.M.: Significance of autoantibodies to oxidatively modified LDL in plasma of children with Down syndrome. Clin. Chem., 2001; 47: 1135-1137
31. Gangemi S., Allegra A., Aguennouz M., Alonci A., Speciale A., Cannavo A., Cristani M., Russo S., Spatari G., Alibrandi A., Musolino C.: Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia. Cancer Invest., 2012; 30: 20-26
32. Gangemi S., Allegra A., Alonci A., Cristani M., Russo S., Speciale A., Penna G., Spatari G., Cannavò A., Bellomo G., Musolino C.: Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm. Res., 2012; 61: 1063-1067
33. Garcia-Fernandez M.I., Gheduzzi D., Boraldi F., Paolinelli C.D., Sanchez P., Valdivielso P., Morilla M.J., Quaglino D., Guerra D., Casolari S., Bercovitch L., Pasquali-Ronchetti I.: Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta, 2008; 1782: 474-481
34. Gelisgen R., Genc H., Kayali R., Oncul M., Benian A., Guralp O., Uludag S., Cakatay U., Albayrak M., Uzun H.: Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res. Clin. Pract., 2011; 94: 404-409
35. Goi G., Baquero-Herrera C., Licastro F., Dogliotti G., Corsi M.M.: Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an ''atheroma-free model'': Down's syndrome. Int. J. Cardiol., 2006; 113: 427-429
36. Grosso S., Longini M., Rodriguez A., Proietti F., Piccini B., Balestri P., Buonocore G.: Oxidative stress in children affected by epileptic encephalopathies. J. Neurol. Sci., 2011; 300: 103-106
37. Guilpain P., Chéreau C., Goulvestre C., Servettaz A., Montani D., Tamas N., Pagnoux C., Hachulla E., Weill B., Guillevin L., Mouthon L., Batteux F.: The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur. Respir. J., 2011; 37: 1503-1513
38. Gutowicz M.: Wpływ reaktywnych form tlenu na os̈rodkowy układ nerwowy. Postępy Hig. Med. Dos̈w., 2011; 65: 104-113
39. Hamouda H.E., Zakaria S.S, Ismail S.A., Khedr M.A., Mayah W.W.: p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia. World J. Gastroenterol., 2011; 17: 2417-2423
40. Hartmann S.E., Pialoux V., Leigh R., Poulin M.J.: Decreased cerebrovascular response to CO2 in post-menopausal females with COPD: role of oxidative stress. Eur. Respir. J., 2012; 40: 1354-1361
41. Herrera E.: Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 2002; 19: 43-55
42. Ignys̈ I., Krauss H., Malewski W., Sosnowski P., Krawczyński M.: Wpływ leczenia 5ASA na wykładniki stresu oksydacyjnego u dzieci z nieswoistymi zapaleniami jelita grubego. Nowa Pediatria, 2003; 7: 99-103
43. Kalousová M., Fialová L., Zima T., Malbohan I.M., Krofta L., Soukupová J., Mikulíková L., Stipek S.: Advanced oxidation protein products in pregnancy. Ceska Gynekol., 2002; 67: 194-197
44. Kalousová M., Zák A., Soukupová J., Stipek S., Malbohan I.M., Zima T.: Advanced glycation and oxidation products in patients with atherosclerosis. Cas. Lek. Cesk., 2005; 144: 385-389
45. Kalousová M., Zima T., Tesar V., Dusilová-Sulková S., Skrha J.: Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background. Mutat. Res., 2005; 579: 37-46
46. Kamanli A., Naziroglu M., Aydilek N., Hecievliyagil C.: Plasma lipid peroxidation and antioxidant levels In patients with rheumatoid arthritis. Cell Biochem. Funct., 2004; 22: 53-57
47. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., Ohno M.: Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002; 162: 221-225
48. Karpel E.: Mediatory ogólnoustrojowej odpowiedzi zapalnej - znaczenie w praktyce klinicznej intensywnej terapii. Anestezjologia Intensywna Terapia, 2001; 3: 181-190
49. Keskin N., Civilibal M., Elevli M., Koldas M., Duru N.S., Ozturk H.: Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura. Pediatr. Nephrol., 2011; 26: 1989-1993
50. Komosinska-Vassev K., Olczyk P., Winsz-Szczotka K., Kuznik- Trocha K., Klimek K., Olczyk K.: Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing. Clin. Chem. Lab. Med., 2012; 50: 557-563
51. Kosova F., Cetin B., Akinci M., Aslan S., Ari Z., Sepici A., Altan N., Cetin A.: Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer. Ann. Surg. Oncol., 2007; 14: 2616-2620
52. Kratz E., Ferens-Sieczkowska M., Zimmer M., Piwowar A.: Oxidative protein damage and oxidative stress markers in the seminal plasma of subfertile men. J. Reproduktionsmed. Endokrinol., 2012; 9: 386-387. 7th European Congress of Andrology (ECA). Berlin, November 28 - December 1 (Abstracts)
53. Król K., Konopka T.: Reaktywne pochodne tlenu i mechanizmy antyoksydacyjne w patogenezie zapaleń przyzębia. Dent. Med. Probl., 2003; 40: 121-128
54. Krzystek-Korpacka M., Neubauer K., Berdowska I., Boehm D., Zielinski B., Petryszyn P., Terlecki G., Paradowski L., Gamian A.: Enhanced formation of advanced oxidation protein products in IBD. Inflamm. Bowel Dis., 2008; 14: 794-802
55. Kucharzik T., Walsh S.V., Chen J., Parkos C.A., Nusrat A.: Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol., 2001; 159: 2001-2009
56. Li Q., Brodsky J.L., Conlin L.K., Pawel B., Glatz A.C., Gafni R.I., Schurgers L., Uitto J., Hakonarson H., Deardorff M.A., Levine M.A.: Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy: genotypic overlap with pseudoxanthoma elasticum. J. Invest. Dermatol., 2014; 134: 658-665
57. Li Q., Jiang Q., Uitto J.: Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6-/-). J. Invest. Dermatol., 2008; 128: 1160-1164
58. Licastro F., Dogliotti G., Goi G., Malavazos A.E., Chiappelli M., Corsi M.M.: Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. Arch. Gerontol. Geriatr., 2007; 44 (Suppl. 1): 225-232
59. Liu H., Han T., Tian J., Zhu Z.Y., Liu Y., Li Y., Xiao S.X., Li Y., Feng Y.Y.: Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Hepatol. Res., 2012; 42: 171-180
60. Llurba E., Gratacós E., Martín-Gallán P., Cabero L., Dominguez C.: A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic. Biol. Med., 2004; 37: 557-570
61. López J., González M.E., Lorigados L., Morales L., Riverón G., Bauzá J.Y.: Oxidative stress markers in surgically treated patients with refractory epilepsy. Clin. Biochem., 2007; 40: 292-298
62. Lozovoy M.A., Simao A.N., Panis C., Rotter M.A., Reiche E.M., Morimoto H.K., Lavado E., Cecchini R., Dichi I.: Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus, 2011; 20: 1250-1259
63. Makker K., Agarwal A., Sharma R.: Oxidative stress and male infertility. Indian J. Med. Res., 2009; 129: 357-367
64. Mancuso M., Bonanni E., LoGerfo A., Orsucci D., Maestri M., Chico L., DiCoscio E., Fabbrini M., Siciliano G., Murri L.: Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med., 2012; 13: 632-636
65. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., Reddy P.H.: Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet., 2006; 15: 1437-1449
66. Matyska-Piekarska E., Łuszczewski A., Łącki J., Wawer I.: Rola stresu oksydacyjnego w etiopatogenezie reumatoidalnego zapalenia stawów. Postępy Hig. Med. Dos̈w., 2006; 60: 617-623
67. Meldrum B.S.: Glutamate as neurotransmitter in the brain: review of physiology and pathology. J. Nutr., 2000; 130 (Suppl. 4S): 1007S-1015S
68. Murdoch J.C., Rodger J.C., Rao S.S., Fletcher C.D., Dunnigan M.G.: Down's syndrome: an atheroma-free model? Br. Med. J., 1977; 2: 226-228
69. Nayyar A.S., Khan M.: In search of malignant transformation: a pilot study. J. Cancer Res. Ther., 2012; 8: 277-281
70. Norheim K.B., Jonsson G., Harboe E., Hanasand M., Gøransson L., Omdal R.: Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren's syndrome. Free Radic. Res., 2012; 46: 141-146
71. Noyan T., Guducuoglu H., Ilhan M.: A study of oxidative stress parameters in anti-Helicobacter pylorus immunoglobulin G positive and negative gastric cancer patients. Yonsei Med. J., 2009; 50: 677-682
72. Noyan T., Güler A., Sekeroglu M.R., Kamaci M.: Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust. N. Z. J. Obstet. Gynaecol., 2006; 46: 486-491
73. Onder M., Gürer M.A.: The multiple faces of Behcet's disease and its aetiological factors. J. Eur. Acad. Dermatol. Venereol., 2001; 15: 126-136
74. Orrell R.W.: Amyotrophic lateral sclerosis:copper/zinc superoxide dismutase (SOD1) gene mutations. Neuromuscul. Disord., 2000; 10: 63-68
75. Pagano G., Castello G.: Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv. Exp. Med. Biol., 2012; 724: 291-299
76. Pasquali-Ronchetti I., Garcia-Fernandez M.I., Boraldi F., Quaglino D., Gheduzzi D., De Vincenzi Paolinelli C., Tiozzo R., Bergamini S., Ceccarelli D., Muscatello U.: Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J. Pathol., 2006; 208: 54-61
77. Perrone S., Mussap M., Longini M., Fanos V., Bellieni C.V., Proietti F., Cataldi L., Buonocore G.: Oxidative kidney damage in preterm newborns during perinatal period. Clin. Biochem., 2007; 40: 656-660
78. Perrone S., Tataranno M.L., Negro S., Cornacchione S., Longini M., Proietti F., Soubasi V., Benders M.J., Van Bel F., Buonocore G.: May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants? J. Matern. Fetal Neonatal Med., 2012; 25 (Suppl. 1): 128-131
79. Perrone S., Tataranno M.L., Negro S., Longini M., Marzocchi B., Proietti F., Iacoponi F., Capitani S., Buonocore G.: Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum. Dev., 2010; 86: 241-244
80. Pialoux V., Mounier R., Brown A.D., Steinback C.D., Rawling J.M., Poulin M.J.: Relationship between oxidative stress and HIF-1α mRNA during sustained hypoxia in humans. Free Radic. Biol. Med., 2009; 46: 321-326
81. Piwowar A.: Aspekty biochemiczne i kliniczne zaawansowanych produktów utleniania białek w chorobach nerek i zaburzeniach metabolicznych. Postępy Hig. Med. Dos̈w., 2014; 68: 179-190
82. Piwowar A., Knapik-Kordecka M., Warwas M.: Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin. Invest. Med., 2010; 33: E109
83. Riverón G., Cuétara E., Hernández E.W., Bécquer P., Acosta T., Marin L., Pereira N., Gutiérrz R., Pupo J., Martinez O., Pandolfi A., Cuevillas G., Llibre J.J.: Oxidative markers and antioxidant defences in patients diagnosed with probable Alzheimer disease. Pharmacologyonline, 2007; 1: 20-24
84. Roberts J.M., Hubel C.A.: Oxidative stress in preeclampsia. Am. J. Obstet. Gynecol., 2004; 190: 1177-1178
85. Rysavá R., Kalousová M., Zima T., Dostál C., Merta M., Tesar V.: Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? Kidney Blood Press. Res., 2007; 30: 1-7
86. Safarpour A.R., Hosseini S.V., Mehrabani D.: Epidemiology of inflammatory bowel diseases in Iran and Asia. Iran. J. Med. Sci., 2013; 38 (Suppl.): 140-149
87. Sandal G., Uras N., Gokmen T., Oguz S.S., Erdeve O., Dilmen U.: Assessment of oxidant/antioxidant system in newborns and their breast milks. J. Matern. Fetal Neonatal Med., 2013; 26: 540-543
88. Siciliano G., Piazza S., Carlesi C., Del Corona A., Franzini M., Pompella A., Malvaldi G., Mancuso M., Paolicchi A., Murri L.: Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. J. Neurol., 2007; 254: 575-580
89. Slowik A., Tomik B., Wolkow P.P., Partyka D., Turaj W., Malecki M.T., Pera J., Dziedzic T., Szczudlik A., Figlewicz D.A.: Paraoxonase gene polymorphisms and sporadic ALS. Neurology, 2006; 67: 766-770
90. Song Y.L., Quan S., Tian J.W., Li H., Chen S.M., Xing F.Q.: Relationship between protein oxidation levels in the follicular fluid and the outcome parameters of in vitro fertilization-embryo transplantation. Nan Fang Yi Ke Da Xue Xue Bao, 2009; 29: 160-163
91. Stanojkovic I., Kotur-Stevuljevic J., Milenkovic B., Spasic S., Vujic T., Stefanovic A., Llic A., Ivanisevic J.: Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir. Med., 2011; 105 (Suppl. 1): S31-S37
92. ͆cibior-Bentkowska D., Czeczot H.: Komórki nowotworowe a stres oksydacyjny. Postępy Hig. Med. Dos̈w., 2009; 63: 58-72
93. Tanaka M., Tokunaga K., Maruyama T., Otagiri M., Tominaga Y., Itoh K., Matsushita K., Komaba H., Fukagawa M.: Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism. Ther. Apher. Dial., 2011; 15 (Suppl. 1): 38-41
94. Tesarová P., Kalousová M., Trnková B., Soukupová J., Argalásová S., Mestek O., Petruzelka L., Zima T.: Carbonyl and oxidative stress in patients with breast cancer - is there a relation to the stage of the disease? Neoplasma, 2007; 54: 219-224
95. Tesarová P., Kvasnicka J., Umlaufová A., Homolková J., Kalousová M., Tesar V.: Soluble adhesion molecules in female patients with breast carcinoma. Cas. Lek. Cesk., 2003; 142: 292-299
96. Toescu V., Nuttall S.L., Martin U., Kendall M.J., Dunne F.: Oxidative stress and normal pregnancy. Clin. Endocrinol., 2002; 57: 609-613
97. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J.: Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007; 39: 44-84
98. Varga P., Oláh A.V., Oláh E.: Biochemical alterations in patients with Down syndrome. Orv. Hetil., 2008; 149: 1203-1213
99. Veyseller B., Aksoy E., Ertas B., Keskin M., Ozturan O., Yildirim Y.S., Bayraktar E.G., Oztürk H.: A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP). B-ENT, 2010; 6: 105-109
100. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen- Khoa T., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B.: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int., 1996; 49: 1304-1313
101. Xian L.W., Li T.P., Wei Y.E., Wu S.P., Ma L.: Relation of advanced oxidation protein products with VEGF and TGF-β1 in colon cancer cells exposed to intermittent hypoxia. Nan Fang Yi Ke Da Xue Xue Bao, 2011; 31: 619-623
102. Xiong Y., Tang H., Li X., Liang Y.B., Liao X.X., Zhan H., Jing X.L., Li Y.J., Ma Z.F.: The expression and clinical implication of advanced oxidized protein products in patients with multiple organ dysfunction syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2008; 20: 542-545
103. Yazici C., Köse K., Calis M., Demir M., Kirnap M., Ates F.: Increased advanced oxidation protein products in Behcet's disease: a new activity marker? Br. J. Dermatol., 2004; 151: 105-111
104. Yazici C., Köse K., Calis M., Kuzugüden S., Kirnap M.: Protein oxidation status in patients with ankylosing spondylitis. Rheumatology, 2004; 43: 1235-1239
105. Yildirim Z., Yildirim F., Ucgun N.I., Kilic N.: The evaluation of the oxidative stress parameters in nondiabetic and diabetic senile cataract patients. Biol. Trace Elem. Res., 2009; 128: 135-143
106. Zamłyński J., Olejek A., Więcek A., Mańka G., Chudek J., Bodzek P., Damasiewicz-Bodzek A.: Wpływ zmian metabolicznych w ciązy prawidłowej i powikłanej cukrzycą na wewnątrzmaciczne wzrastanie płodu. Postępy Hig. Med. Dos̈w., 2005; 59: 490-495
107. Zhong Z.M., Bai L., Chen J.T.: Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-κB pathway. Cell. Physiol. Biochem., 2009; 24: 105-114
108. Zuwała-Jagiełło J., Pazgan-Simon M., Simon K., Warwas M.: Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochim. Pol., 2011; 58: 59-65